151 related articles for article (PubMed ID: 28652924)
21. Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients.
Barraclough KA; Isbel NM; Franklin ME; Lee KJ; Taylor PJ; Campbell SB; Petchey WG; Staatz CE
Ther Drug Monit; 2010 Dec; 32(6):723-33. PubMed ID: 21068647
[TBL] [Abstract][Full Text] [Related]
22. Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipients.
Newland DM; Pak JL; Ali R; Herzog T; Nemeth TL; Tressel W; Kronmal RA; Knorr LR; Albers EL; Friedland-Little JM; Ahmed H; Kemna MS; Hong BJ; Spencer K; Law YM
Clin Transplant; 2023 Nov; 37(11):e15087. PubMed ID: 37526562
[TBL] [Abstract][Full Text] [Related]
23. [Use of limited sampling strategy for estimating area under concentration-versus-time curve of mycophenolate sodium in renal allograft recipients].
Yang SL; Gao X; Wang QH; Zhang J; Cai JQ; Guo JQ; Tang MY; Shang LL; Tan JM
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3841-6. PubMed ID: 24548445
[TBL] [Abstract][Full Text] [Related]
24. A reliable limited sampling strategy for the estimation of mycophenolic acid area under the concentration time curve in adult renal transplant patients in the stable posttransplant period.
Mathew BS; Fleming DH; Annapandian VM; Prasanna S; Prasanna CG; Chandy SJ; John GT
Ther Drug Monit; 2010 Apr; 32(2):136-40. PubMed ID: 20110849
[TBL] [Abstract][Full Text] [Related]
25. Limited-sampling strategy for mycophenolic acid in renal transplant recipients reciving enteric-coated mycophenolate sodium and tacrolimus.
Sánchez Fructuoso AI; Perez-Flores I; Calvo N; Valero R; Matilla E; Ortega D; Del Dedo MA; Fernández-Pérez C; Barrientos A
Ther Drug Monit; 2012 Jun; 34(3):298-305. PubMed ID: 22549501
[TBL] [Abstract][Full Text] [Related]
26. A Limited Sampling Strategy for Therapeutic Drug Monitoring of Mycophenolate Mofetil for Prophylaxis of Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Transplantation.
Gota V; Purohit V; Gurjar M; Nayak L; Punatar S; Gokarn A; Bonda A; Bagal B; Vora CS; Patil A; Nookala M; Khattry N
Cell Transplant; 2020; 29():963689720912925. PubMed ID: 32495641
[TBL] [Abstract][Full Text] [Related]
27. Limited sampling strategy for the estimation of mycophenolic acid area under the plasma concentration-time curve in adult patients undergoing liver transplant.
Zicheng Y; Weixia Z; Hao C; Hongzhuan C
Ther Drug Monit; 2007 Apr; 29(2):207-14. PubMed ID: 17417076
[TBL] [Abstract][Full Text] [Related]
28. Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus.
Pawinski T; Hale M; Korecka M; Fitzsimmons WE; Shaw LM
Clin Chem; 2002 Sep; 48(9):1497-504. PubMed ID: 12194926
[TBL] [Abstract][Full Text] [Related]
29. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
Tett SE; Saint-Marcoux F; Staatz CE; Brunet M; Vinks AA; Miura M; Marquet P; Kuypers DR; van Gelder T; Cattaneo D
Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
[TBL] [Abstract][Full Text] [Related]
30. The Evaluation of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid in Children with Nephrotic Syndrome.
Sobiak J; Resztak M; Chrzanowska M; Zachwieja J; Ostalska-Nowicka D
Molecules; 2021 Jun; 26(12):. PubMed ID: 34207320
[TBL] [Abstract][Full Text] [Related]
31. Limited sampling strategies drawn within 3 hours postdose poorly predict mycophenolic acid area-under-the-curve after enteric-coated mycophenolate sodium.
de Winter BC; van Gelder T; Mathot RA; Glander P; Tedesco-Silva H; Hilbrands L; Budde K; van Hest RM
Ther Drug Monit; 2009 Oct; 31(5):585-91. PubMed ID: 19704401
[TBL] [Abstract][Full Text] [Related]
32. Estimation of the area under the curve for mycophenolic acid in adult renal transplant patients with concomitant tacrolimus using a limited sampling strategy.
Teshima D; Maiguma T; Kaji H; Otsubo K; Kitagawa N; Okabe Y; Sugitani A; Tanaka M; Oishi R
J Clin Pharm Ther; 2008 Apr; 33(2):159-63. PubMed ID: 18315781
[TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis.
Mizaki T; Nobata H; Banno S; Yamaguchi M; Kinashi H; Iwagaitsu S; Ishimoto T; Kuru Y; Ohnishi M; Sako KI; Ito Y
J Pharm Health Care Sci; 2023 Jan; 9(1):1. PubMed ID: 36624529
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of mycophenolic acid and external evaluation of two limited sampling strategies of drug exposure in patients with juvenile systematic lupus erythematosus.
Beaulieu Q; Zhang D; Melki I; Baudouin V; Goldwirst L; Woillard JB; Jacqz-Aigrain E
Eur J Clin Pharmacol; 2022 Jun; 78(6):1003-1010. PubMed ID: 35294622
[TBL] [Abstract][Full Text] [Related]
35. Estimation of Abbreviated Mycophenolic Acid Area Under the Concentration- Time Curve during Stable Post-transplant Period by Limited Sampling Strategy.
Karimani A; Abedi H; Nazemian F; Poortaji A; Pour AHM
Curr Rev Clin Exp Pharmacol; 2021; 16(3):273-280. PubMed ID: 32860364
[TBL] [Abstract][Full Text] [Related]
36. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of Imatinib Mesylate and Development of Limited Sampling Strategies for Estimating the Area under the Concentration-Time Curve of Imatinib Mesylate in Palestinian Patients with Chronic Myeloid Leukemia.
Adawi DH; Fredj NB; Al-Barghouthi A; Dridi I; Lubada M; Manasra M; Aouam K
Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):43-55. PubMed ID: 38006575
[TBL] [Abstract][Full Text] [Related]
38. Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
Weber LT; Lamersdorf T; Shipkova M; Niedmann PD; Wiesel M; Zimmerhackl LB; Staskewitz A; Schütz E; Mehls O; Oellerich M; Armstrong VW; Tönshoff B
Ther Drug Monit; 1999 Oct; 21(5):498-506. PubMed ID: 10519445
[TBL] [Abstract][Full Text] [Related]
39. The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.
Jirasiritham S; Sumethkul V; Mavichak V; Na-Bangchang K
Transplant Proc; 2004 Sep; 36(7):2076-8. PubMed ID: 15518751
[TBL] [Abstract][Full Text] [Related]
40. Limited sampling strategy to predict free mycophenolic acid area under the concentration-time curve in paediatric patients with nephrotic syndrome.
Sobiak J; Żero P; Zachwieja J; Ostalska-Nowicka D; Pawiński T
Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):486-496. PubMed ID: 36846865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
